Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated:  12/13/2017
University of Kansas Medical Center Research Institute
mi
from
Wichita, KA
Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/13/2017
University of Kansas Medical Center Research Institute
mi
from
Wichita, KA
Click here to add this to my saved trials
Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated:  12/13/2017
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/13/2017
Laureate Institute for Brain Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated:  12/13/2017
University of Oklahoma Department of Psychiatry
mi
from
Tulsa, OK
Minocycline and Aspirin in the Treatment of Bipolar Depression
Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Enrolling
Updated: 12/13/2017
University of Oklahoma Department of Psychiatry
mi
from
Tulsa, OK
Click here to add this to my saved trials
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated:  12/13/2017
Salem County Probation Office, Massachusetts Salem District Court, Essex County Superior Court
mi
from
Salem, MA
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated: 12/13/2017
Salem County Probation Office, Massachusetts Salem District Court, Essex County Superior Court
mi
from
Salem, MA
Click here to add this to my saved trials
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated:  12/13/2017
Court and Probation Office, Tarrant County
mi
from
Fort Worth, TX
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated: 12/13/2017
Court and Probation Office, Tarrant County
mi
from
Fort Worth, TX
Click here to add this to my saved trials
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated:  12/13/2017
Court and Probation Office, Saline County
mi
from
Benton, AR
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated: 12/13/2017
Court and Probation Office, Saline County
mi
from
Benton, AR
Click here to add this to my saved trials
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated:  12/13/2017
Court and Probation Office
mi
from
Oregon City, OR
HOPE Demonstration Field Experiment Multisite Evaluation
Multisite Evaluation of the Honest Opportunity With Enforcement Demonstration Field Experiment
Status: Enrolling
Updated: 12/13/2017
Court and Probation Office
mi
from
Oregon City, OR
Click here to add this to my saved trials
Group Interventions for Suicidal African Americans
Group Interventions for Suicidal African Americans
Status: Enrolling
Updated:  12/13/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Group Interventions for Suicidal African Americans
Group Interventions for Suicidal African Americans
Status: Enrolling
Updated: 12/13/2017
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients
ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients
Status: Enrolling
Updated:  12/13/2017
Grady Health System
mi
from
Atlanta, GA
ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients
ReliefLink: A Preventative Mobile Toolkit for Follow-Up Care of Psychiatric Patients
Status: Enrolling
Updated: 12/13/2017
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Parent Interventions to Prevent Student Drinking
Parent Interventions to Prevent Student Drinking
Status: Enrolling
Updated:  12/13/2017
Penn State University
mi
from
University Park, PA
Parent Interventions to Prevent Student Drinking
Parent Interventions to Prevent Student Drinking
Status: Enrolling
Updated: 12/13/2017
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated:  12/14/2017
Blank Children's Hospital
mi
from
Des Moines, IA
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated: 12/14/2017
Blank Children's Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated:  12/14/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated: 12/14/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated:  12/14/2017
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated: 12/14/2017
Children's Hospitals and Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated:  12/14/2017
Children's Mercy Hospital
mi
from
Kansas City, MO
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
PCORI-1306-02918 Evaluation of Parent-based Programs to Support Children After Traumatic Injury
Status: Enrolling
Updated: 12/14/2017
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics
Status: Enrolling
Updated:  12/14/2017
University of Utah
mi
from
Salt Lake City, UT
TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics
Status: Enrolling
Updated: 12/14/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics
Status: Enrolling
Updated:  12/14/2017
Marquette University
mi
from
Milwaukee, WI
TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT)
Creating a Computerized Self-administered Version of Comprehensive Behavioral Intervention for Tics
Status: Enrolling
Updated: 12/14/2017
Marquette University
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
Pharmacotherapy for Cocaine Dependence - 1
Status: Enrolling
Updated:  12/16/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
Pharmacotherapy for Cocaine Dependence - 1
Status: Enrolling
Updated: 12/16/2017
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/18/2017
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/18/2017
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/18/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/18/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/18/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/18/2017
Center for Psychiatry and Behavioral Medicine, Inc.
mi
from
Las Vegas, NV
Click here to add this to my saved trials
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/18/2017
Duke University
mi
from
Durham, NC
NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
A Randomized, Multicenter, Double-Blind, Placebo Controlled, Parallel Group Study of NT0102 in Children (Ages 6 12 Years) With Attention-Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/18/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Parent Intervention to Reduce Binge Drinking
Parent Intervention to Reduce Binge Drinking
Status: Enrolling
Updated:  12/18/2017
Penn State University
mi
from
University Park, PA
Parent Intervention to Reduce Binge Drinking
Parent Intervention to Reduce Binge Drinking
Status: Enrolling
Updated: 12/18/2017
Penn State University
mi
from
University Park, PA
Click here to add this to my saved trials
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Status: Enrolling
Updated:  12/20/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Inspiring Nutritious Selections and Positive Intentions Regarding Eating and Exercise (INSPIRE)
Status: Enrolling
Updated: 12/20/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated:  12/20/2017
Yale Cancer Center
mi
from
New Haven, CT
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated: 12/20/2017
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated:  12/20/2017
Sidney Kimmel Comprehensive Cancer
mi
from
Baltimore, MD
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated: 12/20/2017
Sidney Kimmel Comprehensive Cancer
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated:  12/20/2017
Massey Cancer Center
mi
from
Richmond, VA
Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Phase 1 Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas
Status: Enrolling
Updated: 12/20/2017
Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated:  12/21/2017
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated: 12/21/2017
Maryland Psychiatric Research Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated:  12/21/2017
Keypoint Community Mental Health Centers- Catonsville
mi
from
Baltimore, MD
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated: 12/21/2017
Keypoint Community Mental Health Centers- Catonsville
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated:  12/21/2017
Keypoint Community Mental Health Centers- Dundalk
mi
from
Baltimore, MD
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated: 12/21/2017
Keypoint Community Mental Health Centers- Dundalk
mi
from
Baltimore, MD
Click here to add this to my saved trials
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated:  12/21/2017
VA Maryland Health Care System
mi
from
Baltimore, MD
Biomarker Study of Acamprosate in Schizophrenia
Biomarker Study of Acamprosate in Schizophrenia
Status: Enrolling
Updated: 12/21/2017
VA Maryland Health Care System
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
Post-Traumatic Stress Disorder (PTSD) Treatment in Cardiac Patients
Status: Enrolling
Updated:  12/21/2017
Elmhurst Hospital Center
mi
from
Queens, NY
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
Post-Traumatic Stress Disorder (PTSD) Treatment in Cardiac Patients
Status: Enrolling
Updated: 12/21/2017
Elmhurst Hospital Center
mi
from
Queens, NY
Click here to add this to my saved trials
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
Post-Traumatic Stress Disorder (PTSD) Treatment in Cardiac Patients
Status: Enrolling
Updated:  12/21/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness
Post-Traumatic Stress Disorder (PTSD) Treatment in Cardiac Patients
Status: Enrolling
Updated: 12/21/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
1/2 D-cycloserine Augmentation of CBT for Pediatric OCD
Status: Enrolling
Updated:  12/22/2017
Massachusetts General Hospital
mi
from
Cambridge, MA
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
1/2 D-cycloserine Augmentation of CBT for Pediatric OCD
Status: Enrolling
Updated: 12/22/2017
Massachusetts General Hospital
mi
from
Cambridge, MA
Click here to add this to my saved trials
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
1/2 D-cycloserine Augmentation of CBT for Pediatric OCD
Status: Enrolling
Updated:  12/22/2017
University of South Florida
mi
from
Saint Petersburg, FL
D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD)
1/2 D-cycloserine Augmentation of CBT for Pediatric OCD
Status: Enrolling
Updated: 12/22/2017
University of South Florida
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Employment-Based Depot Naltrexone Clinical Trial II
Employment-Based Depot Naltrexone Clinical Trial II
Status: Enrolling
Updated:  12/27/2017
The Center for Learning and Health
mi
from
Baltimore, MD
Employment-Based Depot Naltrexone Clinical Trial II
Employment-Based Depot Naltrexone Clinical Trial II
Status: Enrolling
Updated: 12/27/2017
The Center for Learning and Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Influenza Challenge in Mood Disorders
Influenza Challenge in Mood Disorders
Status: Enrolling
Updated:  12/27/2017
Laureate Institute for Brian Research
mi
from
Tulsa, OK
Influenza Challenge in Mood Disorders
Influenza Challenge in Mood Disorders
Status: Enrolling
Updated: 12/27/2017
Laureate Institute for Brian Research
mi
from
Tulsa, OK
Click here to add this to my saved trials
Deployment Health in Regular Military Women
Combat, Sexual Assault and Post-Traumatic Stress in OIF/OEF Military Women
Status: Enrolling
Updated:  12/28/2017
Anne G. Sadler, Ph.D.; VAMC
mi
from
Iowa City, IA
Deployment Health in Regular Military Women
Combat, Sexual Assault and Post-Traumatic Stress in OIF/OEF Military Women
Status: Enrolling
Updated: 12/28/2017
Anne G. Sadler, Ph.D.; VAMC
mi
from
Iowa City, IA
Click here to add this to my saved trials
Deployment Health in Regular Military Women
Combat, Sexual Assault and Post-Traumatic Stress in OIF/OEF Military Women
Status: Enrolling
Updated:  12/28/2017
Iowa City VAMC
mi
from
Iowa City, IA
Deployment Health in Regular Military Women
Combat, Sexual Assault and Post-Traumatic Stress in OIF/OEF Military Women
Status: Enrolling
Updated: 12/28/2017
Iowa City VAMC
mi
from
Iowa City, IA
Click here to add this to my saved trials
Online Positive Emotion Skills Intervention for Symptoms of Depression
Online Positive Emotion Skills Intervention for Symptoms of Depression - Pilot Feasibility Trial
Status: Enrolling
Updated:  12/29/2017
University of California, San Francisco, Osher Center for Integrative Medicine
mi
from
San Francisco, CA
Online Positive Emotion Skills Intervention for Symptoms of Depression
Online Positive Emotion Skills Intervention for Symptoms of Depression - Pilot Feasibility Trial
Status: Enrolling
Updated: 12/29/2017
University of California, San Francisco, Osher Center for Integrative Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Harmonex Neuroscience Research
mi
from
Dothan, AL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Harmonex Neuroscience Research
mi
from
Dothan, AL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
ProScience Research Group
mi
from
Culver City, CA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
ProScience Research Group
mi
from
Culver City, CA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Sarkis Clinical Trials
mi
from
Gainesville, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Sarkis Clinical Trials
mi
from
Gainesville, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Indago Research & Health Center, Inc.
mi
from
Hialeah, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Indago Research & Health Center, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Miami Research Associates
mi
from
South Miami, FL
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  1/5/2018
iResearch Atlanta LLC
mi
from
Decatur, GA
Dasotraline Pediatric Extension Study
An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 1/5/2018
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials